Low Dose (d1-5 7) Oral Etoposide Regimen in Intensively Treated Platinum-Resistant Epithelial Ovarian Cancer: The İzmir Oncology Group (IZOG) Study . Ann Med Res 2021, 27 (1), 0029-0033.